Experiment 635231
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Urtica dioica (URTICACEAE) |
| Citation | SOKELAND,J: ALBRECHT,J:. (1997). COMBINED SABAL AND URTICA EXTRACT VS FINASTERIDE IN BPH (ALKEN STAGE 1-11).. 36() |
| Amount utilized | |
| Compound isolated | |
| Disease | IN A RANDOMISED REFERENCE-CONTROLLED MULTICENTRIC DOUBLE BLIND CLINICAL TRIAL THE DRUG PRO 160/120. AND FINASTERIDE WERE STUDIED IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA. CHANGE OF MAXIMUM URINARY FLOW AFTER 24 WEEKS OF THERAPY WAS ASSESSED. AN INCREASE OF URINARY FLOW RATE WAS OBSERVED IN BOTH GROUPS. IN TERMS OF SAFETY ASPECTS, LESS ADVERSE EVENTS OCCURED WITH THE SABAL/URTICA AS WITH FINASTERIDE. A COMMERCIAL PRODUCT, PRO 160/120, WAS USED. |
| Dose amount | 240.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |
| Gender | MALE |